Alzheimer's Drug Discovery Foundation

Description

Alzheimer’s disease is not only about losing the memory of the past. It is about losing your own future - and the future of loved ones - if we do not find a cure. The Alzheimer’s Drug Discovery Foundation (ADDF) is singularly focused on the science that is needed to discover a cure.

About the Alzheimer’s Drug Discovery Foundation

Our sole mission is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer’s disease, related dementias and cognitive aging. Founded in 1998 by Co-Chairmen Leonard and Ronald Lauder, the ADDF awards grants to leading scientists conducting breakthrough drug discovery and early clinical research.

All of the ADDF’s overhead and administrative costs are covered by a private foundation, allowing 100% of funds raised to be used directly for Alzheimer’s drug research and related programs.

The ADDF has established an extraordinary track record of identifying and supporting the best drug discovery and early clinical programs for Alzheimer’s disease at universities and biotechnology companies around the world. Many of the ADDF’s grants are structured as loans or investments which provide a return that can be reinvested in new grants. This venture philanthropy model allows the ADDF to maximize the impact of every dollar donated. It also increases the accountability of the scientists we fund and adds to the number of grants we can make.